Process Development of TRI-999, a Fatty-Acid-Modified HIV Fusion Inhibitory Peptide.
Autor: | Huyi Zhang, Stephen E. Schneider, Brian L. Bray, Paul E. Friedrich, Nicolai A. Tvermoes, Catherine J. Mader, Sheila R. Whight, Toivo E. Niemi, Peter Silinski, Tony Picking, Marquitta Warren, Stephen A. Wring |
---|---|
Zdroj: | Organic Process Research & Development; Dec2007, Vol. 12 Issue 1, p101-110, 10p |
Databáze: | Supplemental Index |
Externí odkaz: |